Position in CADL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$50,592
-$222,975 QoQ
Shares Held
10,325
-78.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MML INVESTORS SERVICES, LLC holds $68,664,661 across 56 Biotechnology names. CADL ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,419 | $14,922,920 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,009 | $13,141,833 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,482 | $5,122,529 | |
| 4 | ARGX |
Argenx SE
|
6,011 | $4,389,532 | |
| 5 | INSM |
INSMED Inc
|
24,773 | $4,050,880 | |
| 6 | RPRX |
Royalty Pharma plc
|
42,269 | $2,027,643 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
58,950 | $1,964,214 | |
| 8 | EXEL |
Exelixis, Inc.
|
40,961 | $1,756,817 |
All Filings in CADL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,592 | 10,325 | Shares | Defined | 2026-05-04 | |
| 2025-03-31 | $273,567 | 48,419 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $427,359 | 49,235 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $154,629 | 22,313 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $454,931 | 73,376 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||